Shoshanna Fischhoff

Despite progress in national leadership positions and independent funding, women still lag behind men in achieving top academic ranks and leadership roles in academic medicine.

Eva L. Feldman sat down with NeurRA Magazine for thier winter issue.

A new study points to a connection between cyanobacterial blooms and ALS survival.

Eva L. Feldman, M.D., Ph.D., talks about how ALS cases are on the rise and the importance of making it a reported disease.

Dr. Feldman talks about the importance of increasing awareness for ALS reporting.

Researchers looked at how diabetes and metabolic syndrome affected pain, neuropathy severity and fiber type.

We are sharing a roundup of our latest ALS publications in honor of ALS Awareness Month.

Findings from this study provide an important new therapy target in ALS.

For Nurses Week, we wanted to spotlight two incredible nurses whose focus is in ALS, Sandy Lemkin and Jayna Duell.

The multi-award-winning thesis was written on work conducted in the NeuroNetwork for Emerging Therapies’s lab.

The New York Times interviewed Eva Feldman, M.D., Ph.D., for "10 Small Things Neurologists Wish You'd Do for Your Brain."

The podcast Factory Factory featured Eva L. Feldman, M.D., Ph.D., exploring preparing faculty for success in leadership positions.

Dr. Feldman spoke about the importance of researching clusters in ALS.

A new grant will fund study of an immune cell that may represent a potential target for treating the disease.

Research found that despite changes in guidelines for peripheral neuropathy testing, actual practices had not changed.